Search results for " Neuromuscular"

showing 10 items of 114 documents

jop-2017-3257-File006 – Supplemental material for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients w…

2018

Supplemental material, jop-2017-3257-File006 for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis by Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz, Miguel Bernardo and PEPs Group in Journal of Psychopharmacology

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110904 Neurology and Neuromuscular Diseases
researchProduct

jop-2017-3257-File005 – Supplemental material for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients w…

2018

Supplemental material, jop-2017-3257-File005 for Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis by Patricia Gassó, Sergi Mas, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Salvador Sarró, Anna Mané, Julio Sanjuan, Adrián Llerena, Amalia Lafuente, Jerónimo Saiz-Ruiz, Miguel Bernardo and PEPs Group in Journal of Psychopharmacology

FOS: PsychologyFOS: Clinical medicine170199 Psychology not elsewhere classified110319 Psychiatry (incl. Psychotherapy)111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110904 Neurology and Neuromuscular Diseases
researchProduct

sj-pdf-1-smo-10.1177_20503121211019889 – Supplemental material for The efficacy of single suture for exit site wound closure and stabilization of hem…

2021

Supplemental material, sj-pdf-1-smo-10.1177_20503121211019889 for The efficacy of single suture for exit site wound closure and stabilization of hemodialysis central tunneled catheter by Tomasz Porazko, Andrzej Piersiak and Marian Klinger in SAGE Open Medicine

FOS: Veterinary sciences111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 Otorhinolaryngology70706 Veterinary MedicineFOS: Clinical medicinefungi110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

sj-pdf-1-smo-10.1177_20503121211019889 – Supplemental material for The efficacy of single suture for exit site wound closure and stabilization of hem…

2021

Supplemental material, sj-pdf-1-smo-10.1177_20503121211019889 for The efficacy of single suture for exit site wound closure and stabilization of hemodialysis central tunneled catheter by Tomasz Porazko, Andrzej Piersiak and Marian Klinger in SAGE Open Medicine

FOS: Veterinary sciences111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 Otorhinolaryngology70706 Veterinary MedicineFOS: Clinical medicinefungi110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia

2021

AbstractAccording to the degree of upper and lower motor neuron degeneration, motor neuron diseases (MND) can be categorized into amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS) or progressive muscular atrophy (PMA). Although several studies have addressed the prevalence and incidence of ALS, there is a high heterogeneity in their results. Besides this, neither concept has been previously studied in PLS or PMA. Thus, the objective of this study was to estimate the prevalence and incidence of MND, (distinguishing ALS, PLS and PMA), in the Spanish regions of Catalonia and Valencia in the period 2011–2019. Two population-based Spanish cohorts were used, one from Catalonia …

MaleMalalties neuromuscularsGene ExpressionSuperoxide Dismutase-10302 clinical medicinePrevalence030212 general & internal medicineAmyotrophic lateral sclerosisEstimation theoryPrimary Lateral Sclerosismedia_commonMotor neuronsMotor Neuronseducation.field_of_studyMultidisciplinaryIncidenceIncidence (epidemiology)QRMiddle AgedProgressive muscular atrophyNeuromuscular diseasesmedicine.anatomical_structureNeurones motoresNeurologyMedicineFemaleRiskSciencemedia_common.quotation_subjectPopulationBiologyArticleMuscular Atrophy Spinal03 medical and health sciencesmedicineHumansMotor Neuron DiseaseEspanyaEstimació Teoria de l'educationAgedEstimationSelection biasMotor neurons -- DiseasesModels StatisticalC9orf72 ProteinAmyotrophic Lateral SclerosisMotor neuronmedicine.diseaseRisk factorsSpainNeurones motores -- MalaltiesMutationBiomarkers030217 neurology & neurosurgeryDemography
researchProduct

Children with special health care needs attending emergency department in Italy: analysis of 3479 cases

2020

Abstract Background Although children with special health care needs (CSHCN) represent a minority of the population, they go through more hospitalizations, more admissions to the Emergency Department (ED), and receive a major number of medical prescriptions, in comparison to general pediatric population. Objectives of the study were to determine the reasons for admission to the ED in Italian CSHCN, and to describe the association between patient’s demographic data, clinical history, and health services requirements. Methods Ad hoc web site was created to collect retrospective data of 3479 visits of CSHCN to the ED in 58 Italian Hospitals. Results Seventy-two percent of patients admitted to …

MaleMetabolic diseaseHospitalization rateCongenital skeletal conditionHospitalization rateChildren with special health care needs; Congenital skeletal condition; Emergency department; Hospitalization rate; Isolated CNS malformation; Metabolic diseases; Multiple AED therapy; Neuromuscular diseases; Syndromic disorders; True isolated microcephaly0302 clinical medicineClinical historyMedicineChildeducation.field_of_studyNeuromuscular diseaseSettore MED/38Disabled ChildrenHospitalizationNeuromuscular diseasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAItalyChild PreschoolFemaleChildren with special health care needEmergency Service Hospitalmedicine.medical_specialtyAdolescentPopulationTriage CodeChildren with special health care needsSyndromic disordersChildren with special health care needs03 medical and health sciencesPharmacotherapy030225 pediatricsHumansMedical prescriptioneducationRetrospective StudiesHealth Services Needs and DemandSyndromic disorderEmergency departmentTrue isolated microcephalybusiness.industryResearchInfant NewbornInfantMetabolic diseases030208 emergency & critical care medicineEmergency departmentChildren with special health care needs Congenital skeletal conditionsEmergency department Hospitalization rate Isolated CNS malformation Metabolic diseases Multiple AED therapy Neuromuscular diseases Syndromic disorders True isolated microcephalyFamily medicineChronic DiseaseMultiple AED therapyIsolated CNS malformationbusinessFacilities and Services UtilizationItalian Journal of Pediatrics
researchProduct

The MITOS system predicts long-term survival in amyotrophic lateral sclerosis

2015

ObjectiveThe choice of adequate proxy for long-term survival, the ultimate outcome in randomised clinical trials (RCT) assessing disease-modifying treatments for amyotrophic lateral sclerosis (ALS), is a key issue. The intrinsic limitations of the ALS Functional Rating Scale-Revised (ALSFRS-R), including non-linearity, multidimensionality and floor-effect, have emerged and its usefulness argued. The ALS Milano-Torino staging (ALS-MITOS) system was proposed as a novel tool to measure the progression of ALS and overcome these limitations. This study was performed to validate the ALS-MITOS as a 6-month proxy of survival in 200 ALS patients followed up to 18 months.MethodsAnalyses were performe…

MalePredictive Value of TestWalkingLogistic regressionALS; MOTOR NEURON DISEASE; NEUROMUSCULAR; RANDOMISED TRIALS; Adult; Aged; Amyotrophic Lateral Sclerosis; Communication; Deglutition; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Noninvasive Ventilation; Predictive Value of Tests; ROC Curve; Respiration; Self Care; Survival Analysis; Walking; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous); Medicine (all)law.inventionALS long-term survival ALSFRS-RDisability EvaluationRandomized controlled triallawNEUROMUSCULARAmyotrophic lateral sclerosisMOTOR NEURON DISEASEALS; MOTOR NEURON DISEASE; NEUROMUSCULAR; RANDOMISED TRIALS; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous)CommunicationRespirationMedicine (all)Area under the curveMiddle Agedals motor neuron disease neuromuscular randomised trialsPsychiatry and Mental HealthPredictive value of testsDisease ProgressionSettore MED/26 - NeurologiaFemaleSurvival AnalysiHumanAdultmedicine.medical_specialtyNOSwallowingDouble-Blind MethodArts and Humanities (miscellaneous)Predictive Value of TestsInternal medicinemedicineRANDOMISED TRIALSHumansSurvival analysisAgedNoninvasive VentilationReceiver operating characteristicbusiness.industryAmyotrophic Lateral Sclerosisals; motor neuron disease; neuromuscular; randomised trials; adult; aged; amyotrophic lateral sclerosis; communication; deglutition; disability evaluation; disease progression; double-blind method; female; humans; male; middle aged; noninvasive ventilation; predictive value of tests; roc curve; respiration; self care; survival analysis; walking; neurology clinical; psychiatry and mental health; surgery; arts and humanities ; medicinemedicine.diseaseSurvival AnalysisSurgeryDeglutitionSelf CareALS; MOTOR NEURON DISEASE; NEUROMUSCULAR; RANDOMISED TRIALS; Adult; Aged; Amyotrophic Lateral Sclerosis; Communication; Deglutition; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Noninvasive Ventilation; Predictive Value of Tests; ROC Curve; Respiration; Self Care; Survival Analysis; Walking; Surgery; Arts and Humanities (miscellaneous); Neurology (clinical); Psychiatry and Mental HealthROC CurveSurgeryNeurology (clinical)ALSbusinessAmyotrophic Lateral Sclerosi
researchProduct

Antimicrobial consumption and antimicrobial resistance: A snapshot of an Italian neuromuscular rehabilitation center

2017

The paper presents a snapshot of the incidence of antimicrobial-resistant microorganisms and antimicrobial consumption in an Italian rehabilitation center over a two-year period (2014-2015). Data on microorganism identification and antimicrobial susceptibility testing were obtained from the diagnostic laboratory of the hospital. A set of indicators was assessed, including the incidence density of resistant isolates per 1000 patient-days (IDRI). Data on antimicrobial consumption, semi-annually, obtained from the hospital pharmacy, were expressed as Defined Daily Dose (DDD) per 1000 patient-days. The most frequently isolated microorganism was Klebsiella pneumoniae (19.3%), and a significant i…

Microbiology (medical)GastrointestinalCathetersBacteriaSettore MED/17 - Malattie InfettiveAntimicrobial consumption; Antimicrobial resistance; DDD per 1000 patient-days; Healthcare-associated infections; Rehabilitation hospital; Anti-Bacterial Agents; Bacteria; Catheters; Drug Utilization; Intubation Gastrointestinal; Italy; Neuromuscular Diseases; Risk Factors; Drug Resistance Bacterial; Rehabilitation CentersHealthcare-Associated infections.Drug ResistanceBacterialNeuromuscular DiseasesHealthcare-associated infectionsAntimicrobial resistanceRehabilitation hospitalDDD per 1000 patient-daysRehabilitation CentersDrug UtilizationAnti-Bacterial AgentsItalyRisk FactorsAntimicrobial consumptionDrug Resistance BacterialIntubationIntubation GastrointestinalAntimicrobial consumption; Antimicrobial resistance; DDD per 1000 patient-days; Healthcare-Associated infections.; Rehabilitation hospital; Microbiology (medical)DDD per 1000 patient-day
researchProduct

Rituximab in AChR subtype of myasthenia gravis: systematic review

2020

Myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular junction characterised by an autoantibody against acetylcholine receptor (AChR-Ab), autoantibody against muscle-specific kinase (MuSK-Ab), lipoprotein-related protein 4 or agrin in the postsynaptic membrane at the neuromuscular junction. Many patients are resistant to conventional treatment and effective therapies are needed. Rituximab (RTX) is a monoclonal antibody directed against CD20 antigen on B cells which has been successfully employed in anti-MuSK-Ab+MG, but the efficacy in anti-AChR-Ab+MG is still debated. The purpose of this systematic review was to describe the best evidence for RTX in the acetylcholine …

Oncologymedicine.medical_specialtyneuroimmunologyNeuromuscular junctionimmunology03 medical and health sciences0302 clinical medicineInternal medicineMyasthenia GravismedicineHumansImmunologic FactorsReceptors Cholinergic030304 developmental biologyAcetylcholine receptorCD200303 health sciencesAgrinbiologyimmunology; myasthenia; neuroimmunology; neuromuscularbusiness.industryAutoantibodyReceptor Protein-Tyrosine Kinasesmedicine.diseaseMyasthenia gravismyastheniaDiscontinuationPsychiatry and Mental healthTreatment Outcomemedicine.anatomical_structurebiology.proteinSettore MED/26 - NeurologiaSurgeryRituximabneuromuscularNeurology (clinical)Rituximabbusiness030217 neurology & neurosurgerymedicine.drugJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Bioprogressive Paradigm in Physiotherapeutic and Antiaging Strategies: A Review

2018

This review updates the knowledge on the use of bioprogressive philosophy in current rehabilitation paradigms, focusing on age-related ailments and antiaging strategies. It is a holistic approach that combines aspects of biology and function into the realm of rehabilitation therapy. The bioprogressive philosophy, with assistance of modern technological developments, such as microgravity-producing devices and techniques, enables personalized and targeted therapeutic approach that seems the most effective in rehabilitation and prevention of neuro-myo-sensory disorders that compromise the homeostatic body harmony, particularly in old age. The review defines the aging, discusses the most common…

Proprioceptive neuromuscular facilitationAgingPhysical dysfunctionAntiaging strategyRehabilitationPhysiotherapyBioprogressive paradigm
researchProduct